206
Views
13
CrossRef citations to date
0
Altmetric
Original Research

End-of-life care in individuals with respiratory diseases: a population study comparing the dying experience between those with chronic obstructive pulmonary disease and lung cancer

ORCID Icon, , , ORCID Icon, , , & show all
Pages 1691-1701 | Published online: 31 Jul 2019

References

  • Chapman KR, Bourbeau J, Rance L. The burden of COPD in Canada: results from the confronting COPD survey. Respir Med. 2003;97(Suppl C):S23–S31. doi:10.1016/S0954-6111(03)80022-7
  • Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet. 1997;349(9064):1498–1504. doi:10.1016/S0140-6736(96)07492-29167458
  • Doucet M, Rochette L, Hamel D. Incidence, prevalence, and mortality trends in chronic obstructive pulmonary disease over 2001 to 2011: a public health point of view of the burden. Can Respir J. 2016;2016:7518287. doi:10.1155/2016/751828727478397
  • Gershon AS, Wang C, Wilton AS, Raut R, To T. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med. 2010;170(6):560–565. doi:10.1001/archinternmed.2010.1720308643
  • Jinjuvadia C, Jinjuvadia R, Mandapakala C, Durairajan N, Liangpunsakul S, Soubani AO. Trends in outcomes, financial burden, and mortality for acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD) in the United States from 2002 to 2010. COPD. 2017;14(1):72–79. doi:10.1080/15412555.2016.119966927419254
  • Lopez-Campos JL, Ruiz-Ramos M, Soriano JB. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994–2010: a joinpoint regression analysis. Lancet Respir Med. 2014;2(1):54–62. doi:10.1016/S2213-2600(13)70232-724461902
  • Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970–2002. JAMA. 2005;294(10):1255–1259. doi:10.1001/jama.294.10.125516160134
  • Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends–an update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16–27. doi:10.1158/1055-9965.EPI-15-057826667886
  • Spathis A, Booth S. End of life care in chronic obstructive pulmonary disease: in search of a good death. Int J Chron Obstruct Pulmon Dis. 2008;3(1):11–29.18488426
  • Pantilat SZ, O’Riordan DL, Dibble SL, Landefeld CS. Longitudinal assessment of symptom severity among hospitalized elders diagnosed with cancer, heart failure, and chronic obstructive pulmonary disease. J Hosp Med. 2012;7(7):567–572. doi:10.1002/jhm.192522371388
  • Au DH, Udris EM, Fihn SD, McDonell MB, Curtis JR. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med. 2006;166(3):326–331. doi:10.1001/archinte.166.3.32616476873
  • Claessens MT, Lynn J, Zhong Z, et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to understand prognoses and preferences for outcomes and risks of treatments. J Am Geriatr Soc. 2000;48(5 Suppl):S146–S153. doi:10.1111/j.1532-5415.2000.tb03124.x10809468
  • Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000;55(12):1000–1006. doi:10.1136/thorax.55.12.100011083884
  • Goodridge D, Lawson J, Duggleby W, Marciniuk D, Rennie D, Stang M. Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life. Respir Med. 2008;102(6):885–891. doi:10.1016/j.rmed.2008.01.00718313278
  • Bloom CI, Slaich B, Morales DR, Smeeth L, Stone P, Quint JK. Low uptake of palliative care for COPD patients within primary care in the UK. Eur Respir J. 2018;51:2. doi:10.1183/13993003.01879-2017
  • Hyasat K, Sriram KB. Evaluation of the patterns of care provided to patients with COPD compared to patients with lung cancer who died in hospital. Am J Hosp Palliat Care. 2016;33(8):717–722. doi:10.1177/104990911558639525987648
  • Faes K, De Frene V, Cohen J, Annemans L. Resource use and health care costs of COPD patients at the end of life: a systematic review. J Pain Symptom Manage. 2016;52(4):588–599. doi:10.1016/j.jpainsymman.2016.04.00727401511
  • Lau KS, Tse DM, Tsan Chen TW, Lam PT, Lam WM, Chan KS. Comparing noncancer and cancer deaths in Hong Kong: a retrospective review. J Pain Symptom Manage. 2010;40(5):704–714. doi:10.1016/j.jpainsymman.2010.02.02320728302
  • Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA. 2009;302(7):741–749. doi:10.1001/jama.2009.119819690306
  • Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–742. doi:10.1056/NEJMoa100067820818875
  • Casarett D, Pickard A, Bailey FA, et al. Do palliative consultations improve patient outcomes? J Am Geriatr Soc. 2008;56(4):593–599. doi:10.1111/j.1532-5415.2007.01610.x18205757
  • Brumley RD, Enguidanos S, Cherin DA. Effectiveness of a home-based palliative care program for end-of-life. J Palliat Med. 2003;6(5):715–724. doi:10.1089/10966210332251522014622451
  • Mrad C, Abougergi MS, One Step DB. Forward, two steps back: trends in aggressive inpatient care at the end of life for patients with stage IV lung cancer. J Oncol Pract. 2018 JOP1800515. doi:10.1200/JOP.18.00515
  • Cohen J, Beernaert K, Van Den Block L, et al. Differences in place of death between lung cancer and COPD patients: a 14-country study using death certificate data. NPJ Prim Care Respir Med. 2017;27(1):14. doi:10.1038/s41533-017-0017-y28258277
  • Husted MG, Kriegbaum M, Kirkegaard N, Lange P. The use of healthcare resources in the last 3 years of life in patients with COPD and lung cancer in Denmark. A retrospective nationwide study. BMJ Support Palliat Care. 2014;4(2):146–151. doi:10.1136/bmjspcare-2013-000601
  • Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T. Identifying individuals with physcian diagnosed COPD in health administrative databases. COPD. 2009;6(5):388–394.19863368
  • Robles SC, Marrett LD, Clarke EA, Risch HA. An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol. 1988;41(5):495–501.3367181
  • McLaughlin JR, Kreiger N, Marrett LD, Holowaty EJ. Cancer incidence registration and trends in Ontario. Eur J Cancer. 1991;27(11):1520–1524.1835870
  • Hall S, Schulze K, Groome P, Mackillop W, Holowaty E. Using cancer registry data for survival studies: the example of the Ontario cancer registry. J Clin Epidemiol. 2006;59(1):67–76. doi:10.1016/j.jclinepi.2005.05.00116360563
  • Brenner DR, Tammemagi MC, Bull SB, Pinnaduwaje D, Andrulis IL. Using cancer registry data: agreement in cause-of-death data between the Ontario cancer registry and a longitudinal study of breast cancer patients. Chronic Dis Can. 2009;30(1):16–19.20031084
  • Kralj B. Measuring ‘rurality’ for purposes of health-care planning: an empirical measure for Ontario. Ont Med Rev. 2000;67:33-52.
  • Denny K, Davidson MJ. Area-based socio-economic measures as tools for health disparities research, policy and planning. Can J Public Health. 2012;103(8 Suppl 2):S4–S6.23618070
  • Pefoyo AJ, Bronskill SE, Gruneir A, et al. The increasing burden and complexity of multimorbidity. BMC Public Health. 2015;15:415. doi:10.1186/s12889-015-1733-225903064
  • Mondor L, Maxwell CJ, Bronskill SE, Gruneir A, Wodchis WP. The relative impact of chronic conditions and multimorbidity on health-related quality of life in Ontario long-stay home care clients. Qual Life Res. 2016;25(10):2619–2632. doi:10.1007/s11136-016-1281-y27052421
  • Mondor L, Maxwell CJ, Hogan DB, et al. Multimorbidity and healthcare utilization among home care clients with dementia in Ontario, Canada: a retrospective analysis of a population-based cohort. PLoS Med. 2017;14(3):e1002249. doi:10.1371/journal.pmed.100223028267802
  • Thavorn K, Maxwell CJ, Gruneir A, et al. Effect of socio-demographic factors on the association between multimorbidity and healthcare costs: a population-based, retrospective cohort study. BMJ Open. 2017;7(10):e017264. doi:10.1136/bmjopen-2017-017264
  • Petrosyan Y, Bai YQ, Kone Pefoyo AJ, et al. The relationship between diabetes care quality and diabetes-related hospitalizations and the modifying role of comorbidity. Can J Diabetes. 2017;41(1):17–25. doi:10.1016/j.jcjd.2016.06.00627789111
  • Meffert C, Hatami I, Xander C, Becker G. Palliative care needs in COPD patients with or without cancer: an epidemiological study. Eur Respir J. 2015;46(3):663–670. doi:10.1183/09031936.0020861426022963
  • Gershon AS, Maclagan LC, Luo J, et al. End of life strategies among patients with advanced Chronic Obstructive Pulmonary Disease (COPD). Am J Respir Crit Care Med. 2018;198(11):1389-1396. doi:10.1164/rccm.201803-0592OC
  • Brown CR, Hsu AT, Kendall C, et al. How are physicians delivering palliative care? A population-based retrospective cohort study describing the mix of generalist and specialist palliative care models in the last year of life. Palliat Med. 2018 269216318780223. doi:10.1177/0269216318780223
  • Isenberg S, Hsu A, Spruin S, Budhwani S, Gill A, Goldman R, Tanuseputro P. Evaluating the Impact and Costs of Home-Based Palliative Care at the System Level. The Journal of Pain and Symptom Management 2019;57(2):410. doi:10.1016/j.jpainsymman.2018.12.122.
  • Wodchis WP, Bushmeneva K, Nikitovic M, McKillop I Guidelines on person-level costing using administrative databases in Ontario. Working Paper Series Toronto: Health System Performance Research Network. 2013;1.
  • Gregori D, Petrinco M, Bo S, Desideri A, Merletti F, Pagano E. Regression models for analyzing costs and their determinants in health care: an introductory review. Int J Qual Health Care. 2011;23(3):331–341. doi:10.1093/intqhc/mzr01021504959
  • Halpin DMG. Palliative care for people with COPD: effective but underused. Eur Respir J. 2018;51:2. doi:10.1183/13993003.02645-2017
  • Brown CE, Jecker NS, Curtis JR. Inadequate palliative care in chronic lung disease. An issue of health care inequality. Ann Am Thorac Soc. 2016;13(3):311–316. doi:10.1513/AnnalsATS.201510-666PS26730490
  • Rocker GM, Dodek PM, Heyland DK. Canadian researchers at the end of life N. Toward optimal end-of-life care for patients with advanced chronic obstructive pulmonary disease: insights from a multicentre study. Can Respir J. 2008;15(5):249–254. doi:10.1155/2008/36916218716686
  • Boland J, Martin J, Wells AU, Ross JR. Palliative care for people with non-malignant lung disease: summary of current evidence and future direction. Palliat Med. 2013;27(9):811–816. doi:10.1177/026921631349346723838376
  • Nickerson JW. A needs assessment to determine the need for respiratory therapy in complex continuing care: a methods paper. Can J Respir Ther. 2015;51(3):55–59.26283869
  • Wichmann AB, van Dam H, Thoonsen B, Boer TA, Engels Y, Groenewoud AS. Advance care planning conversations with palliative patients: looking through the GP’s eyes. BMC Fam Pract. 2018;19(1):184. doi:10.1186/s12875-018-0787-530486774
  • Rocker GM, Simpson AC, Horton R. Palliative care in advanced lung disease: the challenge of integrating palliation into everyday care. Chest. 2015;148(3):801–809. doi:10.1378/chest.14-259325742140